At Freenome, we are seeking a Clinical Laboratory Associate I to help grow the Freenome Clinical Laboratory Analytical team. The ideal candidate is dependable, flexible, with attention to detail and is team oriented. This person is responsible for all things related to sample processing and equipment maintenance. You are passionate about making a direct impact on patient lives through attention to detail, diligence in the lab, and cooperative teamwork. You will have a significant impact on the continued growth of a high profile technology organization that is changing the landscape on early cancer detection.
This role reports to the Supervisor, Analytical Laboratory.
This position follows one of two schedules, (subject to change based on business needs):
Onboarding training for Shift 2 takes place Monday–Friday, 7:30 a.m.–4:00 p.m., and may last up to two (2) months. Periodic extended hours and weekend rotations may be required for approximately six (6) months.
Contractors may be hired through a third-party provider and will be considered contingent workers. We invite you to check out our career page @ freenome.com/job-openings/ for additional company information.
Freenome is proud to be an equal opportunity employer and we value diversity. Freenome does not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.
Applicants have rights under Federal Employment Laws.
California applicants please review the CCPA Notice at Collection here:
#LI-ONSITE

Freenome is a high-growth biotech company on a mission since 2014 to create tools that empower everyone to prevent, detect, and treat their disease.
To achieve this mission, Freenome is developing next-generation blood tests to detect cancer in its earliest, most treatable stages using our multiomics platform and machine learning techniques. Our first blood test will detect early-stage colorectal cancer and advanced adenomas.
We have raised more than $1.1 billion from leading investors like Perceptive Advisors, RA Capital Management, Roche Venture Fund, Kaiser Permanente, Novartis and the American Cancer Society’s BrightEdge Ventures.
A ‘Freenomer’ is a mission-driven employee who is fueled by the opportunity to make a positive impact on patients' lives, who thrives in a culture of respect and cross collaboration, and whose work makes a significant impact on the company and their career.